Mignon L. Loh

Hematology | Oncology
4800 Sand Point Way NE
Seattle, WA 98105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 217 publications

Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia.

Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia.

Journal: Blood advances
Published: May 05, 2026

Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia.

Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia.

Journal: Blood advances
Published: May 05, 2026

Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes.

Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes.

Journal: Blood advances
Published: January 08, 2026

Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia.

Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia.

Journal: Blood advances
Published: January 07, 2026

Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2026

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia
Published: October 06, 2025

Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge.

Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge.

Journal: British journal of haematology
Published: September 17, 2025

Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.

Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.

Journal: Pediatric blood & cancer
Published: July 24, 2025

Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia. Reply.

Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia. Reply.

Journal: The New England journal of medicine
Published: June 11, 2025

Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology Group.

Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology Group.

Journal: Pediatric blood & cancer
Published: May 27, 2025

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.

Journal: Blood advances
Published: April 29, 2025

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.

Journal: Blood advances
Published: April 01, 2025
Showing 1-12 of 217

Last Updated: 09/26/2026